B-166 Analytical Performance of Pictor’s PictHealth™ Immunoscreen ENA Targeted Proteomics Assay Compared with Commercial Platforms
Extractable nuclear antigen (ENA) antibody testing is central to the diagnosis of systemic autoimmune rheumatic diseases (SARDs). However, widely used multiplex platforms often require specialized instruments and high operational costs, limiting accessibility in many laboratories. We evaluated the performance of...